Physician profile
David Jesse Gerth
NPI 1649475583
$9,217.38
in general payments reported to CMS, 2019-2025
17 companies · $1,366 in 2025
The $1,366 reported for 2025 was more than what 86% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,198 · 2020: $13.99 · 2021: $141 · 2022: $478 · 2023: $2,457 · 2024: $1,565 · 2025: $1,366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,381 · Food and Beverage: $2,057 · Debt Forgiveness: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,380.80 |
| Food and Beverage | $2,056.52 |
| Debt Forgiveness | $950.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,666.68 | 2019 | |
| Abbvie INC. | $2,427.55 | 2023-2025 | |
| Mentor Worldwide LLC | $1,044.97 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Johnson & Johnson Health Care Systems INC. | $950.00 | 2025 | |
| Medical Device Business Services, INC. | $603.87 | 2024 | |
| Integra Lifesciences Corporation | $416.35 | 2019-2022 | |
| Surgical Innovation Associates, INC. | $316.84 | 2022 | |
| Revance Therapeutics, INC. | $167.25 | 2024 | Daxxify |
| Sanara Medtech INC. | $139.15 | 2023 | Celleraterx |
| Melinta Therapeutics, LLC | $133.38 | 2019 | |
| Access Pro Medical, LLC | $131.15 | 2023 | Matriderm |
| Biopro, INC. | $66.67 | 2019 | |
| Axogen | $61.43 | 2019 | |
| Motiva USA, LLC | $42.92 | 2025 | |
| Smith+Nephew, INC. | $24.00 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $13.99 | 2020 | |
| Polarityte, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Gerth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.